Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/04/2021 - 9 minutes
Cystic fibrosis
Why Listening to Patient Organizations is Key in Drug Development
As the biotech industry flourishes and therapies become more targeted and personalized, the need for…
27/05/2020 - 11 minutes
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
24/03/2020 - 9 minutes
Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
03/01/2020 - 2 minutes
Robotic Organoid Platform to Boost Personalized Medicine
The Swiss biotech Sun Bioscience has launched a robotic platform designed to standardize the production…
11/12/2018 - 3 minutes
New Gene Therapy Could Treat Cystic Fibrosis With One Dose
A new partnership in the UK will develop a gene therapy for cystic fibrosis that…
06/08/2018 - 3 minutes
British Biotech Raises £29M Round to Fight Lung Disease
Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for…
12/04/2018 - 2 minutes
A Dutch Company on the Quest Against Cystic Fibrosis
ProQR is the result of a personal quest against cystic fibrosis started by its CEO,…
12/03/2018 - 6 minutes
London Biotech Uses Unique Double Mechanism of Action to Treat Cystic Fibrosis
Verona Pharma obtained positive Phase IIa trial results for a unique cystic fibrosis drug that…
02/03/2018 - 2 minutes
A Breath of Fresh Air for Biotechs Working on Cystic Fibrosis Therapies?
Researchers from the University of Zurich have determined the structure of a chloride channel, which could…
14/12/2017 - 3 minutes
Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout
Galapagos will receive a $10M (€8.5M) milestone payment from its collaborator, AbbVie, after their cystic fibrosis…
22/11/2017 - 3 minutes
Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low
ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact…
14/11/2017 - 2 minutes
